Hospira Inc., A Pfizer Company recalls METRONIDazole Injection, USP 500 mg (5 mg/mL) in 100 mL Single Dose Flexible Container, Rx only, For IV Use, Hospira In…
- Recall date
- February 10, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0480-2017
- FDA classification
- Class II
- Brand / firm
- Hospira Inc., A Pfizer Company
- Sold / distributed
- Nationwide and Puerto Rico
Why it was recalled
Lack of Sterility Assurance: customer report of leaking bag
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
METRONIDazole Injection, USP 500 mg (5 mg/mL) in 100 mL Single Dose Flexible Container, Rx only, For IV Use, Hospira Inc., Lake Forest, IL --- NDC 0409-7811-24
Get recall alerts
Free email alert whenever Hospira Inc., A Pfizer Company has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Hospira Inc., A Pfizer Company